Clinical Trial Update: PS-341 in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of PS-341 (bortezomib) in women with metastatic breast cancer has completed; the update notes the study status but does not include results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Northwestern University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED